An improved gas chromatography assay for topiramate monitoring in pediatric patients.
An improved micromethod involving capillary gas chromatographic assay with liquid-liquid extraction and nitrogen phosphorus detection (GC/NPD) was developed and validated for the determination of topiramate (TPM) in human body fluids. The galactopyranose analog of TPM was used as the internal standard. Capillary gas chromatographic conditions yielded typical retention times of 6.8 min for TPM and 7.2 min for the internal standard. Calibrations were linear between 1.0 and 32 microg/mL. Between-day precision (n = 17) for three serum controls (3.0, 10, and 24.5 microg/mL) resulted in coefficients of variation of 6.9%, 7.3%, and 4.9%, respectively. The limit of detection was 0.42 microg/mL. There was an excellent linear correlation between the fluorescence-polarization immunoassay (FPIA) and GC/NPD determinations of 56 patient specimens (r2 = 0.981). Chromatograms showed no interfering peaks with the respective blank human samples or from many commonly prescribed drugs. Because of improved specificity and decreased sample volume requirements, this micromethod should be particularly useful for monitoring TPM therapy in pediatric patients, for patients with impaired renal function, and for research studies.
Tang
P H
PH
Division of Pediatric Neurology, The Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA.
Miles
M V
MV
Glauser
T A
TA
Coletta
L
L
Doughman
N
N
Doose
D
D
Frey
M
M
DeGrauw
A
A
D000927:Anticonvulsants / Q000032:analysis*; D002648:Child; D002849:Chromatography, Gas; D016903:Drug Monitoring; D005454:Fluorescence Polarization; D005632:Fructose / Q000031:analogs & derivatives* / Q000032:analysis; D006801:Humans; D007118:Immunoassay; D000077236:Topiramate
D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose